Publikationsverzeichnis von PD Dr. Carsten Krüger

Originalarbeiten

Krüger C, Erdmann E, Näbauer M, Beuckelmann DJ, 1994. Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic hamsters (strain BIO 14.6) with congestive heart failure. Cell Calcium 16: 500-508.

Haunstetter A, Haass M, Yi X, Krüger C, Kübler W, 1994. Muscarinic inhibition of cardiac norepinephrine and neuropeptide Y release during ischemia and reperfusion. Am J Physiol 267 (Regul Integr Comp Physiol 36): R1552-R1558.

Krüger C, Haunstetter A, Gerber S, Serf C, Kaufmann A, Kübler W, Haass M, 1995. Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: modulation by single components of ischaemia. J Mol Cell Cardiol 27: 1491-1506.

Beuckelmann DJ, Näbauer M, Krüger C, Erdmann E, 1995. Altered diastolic [Ca²⁺]_i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J 129: 684-689.

Gerber SH, Haunstetter A, Krüger C, Kaufmann A, Nobiling R, Haass M, 1995. Role of [Na⁺]_i and [Ca²⁺]_i in nicotine-induced norepinephrine release from bovine adrenal chromaffin cells. Am J Physiol 269 (Cell Physiol 38): C572-C581.

The Pimobendan in Congestive Heart Failure (PICO) Investigators, 1996. Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial. Heart 76: 223-231.

Krüger C, Kalenka A, Haunstetter A, Schweizer M, Maier C, Rühle U, Ehmke H, Kübler W, Haass M, 1997. Baroreflex sensitivity and heart rate variability in conscious rats with myocardial infarction. Am J Physiol 273 (Heart Circ Physiol 42): H2240-H2247.

Haass M, Serf C, Gerber S, Krüger C, Haunstetter A, Vahl CF, Nobiling R, Kübler W, 1997. Dual effect of digitalis glycosides on norepinephrine release from human atrial tissue and bovine adrenal chromaffin cells: differential dependence on [Na⁺]_i and [Ca²⁺]_i. J Mol Cell Cardiol 29: 1615-1627.

Gerber S H, Heyer C, Krüger C, Hagl S, Kübler W, Haass M, 1999. Influence of Bretschneider’s cardioplegia on norepinephrine release from isolated perfused guinea-pig hearts. J Mol Cell Cardiol 31: 89-99.

Krüger C, Landerer V, Zugck C, Ehmke H, Kübler W, Haass M, 2000. The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction. Cardiovasc Res 45: 900-912.

Zugck C, Krüger C, Dürr S, Gerber S H, Haunstetter A, Hornig K, Kübler W, Haass M, 2000. Is the 6-minute walk test a reliable substitute for peak ogygen uptake in patients with dilated cardiomyopathy? Eur Heart J 21: 540-549.

Zugck C, Krüger C, Kell R, Körber S, Schellberg D, Kübler W, Haass M, 2001. Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail 3: 577-585.

Hansen A, Haass M, Zugck C, Krüger C, Unnebrink K, Zimmermann R, Kübler W, Kücherer H, 2001. Prognostic value of doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 37: 1049-1055.

Zugck C, Gerhards A, Kell R, Krüger C, Schellberg D, Katz N, Haass M, 2001. BNP ist ANP, Endothelin und Noradrenalin als Prognoseindikator bei Patienten mit chronischer Herzinsuffizienz überlegen. J Kardiol 8: 286-292.

Krüger C, Zugck C, Landerer V, Kübler W, Haass M, 2001. d,l-Sotalol enhances baroreflex sensitivity in conscious rats surviving acute myocardial infarction. Pharmacol Res 44: 13-20.

Hansen A, Krüger C, Hardt SE, Haass M, Kücherer H, 2001. Echocardiographic quantification of left ventricular asynergy in coronary artery disease with Fourier phase imaging. Int J Card Imag 17: 81-88.

Krüger C, Lahm T, Zugck C, Kell R, Schweizer M, Schellberg D, Kübler W, Haass M, 2002. Heart rate variability enhances the prognostic value of established parameters in patients with congestive heart failure. Z Kardiol 91: 1003-1012.

Hansen A, Zugck C, Krüger C, Unnebrink K, Zimmermann R, Kübler W, Kücherer H, 2002. Diastolic dysfunction: a new selection criterion in heart transplant candidates? New Arts Cardiol 1: 14-15.

Haunstetter A, Schulze Icking B, Backs J, Krüger C, Haass M, 2002. Differential effects of acidosis, high potassium concentrations, and metabolic inhibition on noradrenaline release and its presynaptic muscarinic regulation. Pharmacol Res 45: 221-228.

Zugck C, Haunstetter A, Krüger C, Kell R, Schellberg D, Kübler W, Haass M, 2002. Impact of ß-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 39: 1615-1622.

Becker R, Haass M, Ick D, Krüger C, Bauer A, Senges JC, Schreiner KD, Voss F, Hilbel T, Kübler W, Schöls W, 2003. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 98:  259-266.

Haass M, Hasslacher C, Krüger C, 2008. Diabetes mellitus und Herzinsuffizienz. Kardiologie up2date 4:  31-42.

Buchbeiträge

HASSLACHER C, FRITSCHKA E, KRETZSCHMAR U, KRÜGER C, MILTNER P, MORATH C, PFEIFFER A, QUASCHNING T, SPRANGER J, WANNER C, WEISE D, ZEIER M, 2009 (3. Aufl.). Diabetische Nephropathie - Prävention und Therapie. UNI-MED Verlag, Bremen.

STEINBERG G, LOSSNITZER N, SCHELLBERG D, MÜLLER-TASCH T, KRÜGER C, HAASS M, LADWIG K, HERZOG W, JÜNGER J, 2011/12. Peak oxygen uptake and left ventricular ejection fraction, but noch depressive symptoms are associated with cognitive impairment in chronic heart failure patients. Intl J General Med (im Druck).